Keyphrases
Inflammatory Biomarkers
100%
Chronic Obstructive Pulmonary Disease
100%
Comorbidity
100%
Fibrinogen
50%
C-reactive Protein
50%
Leukocyte Count
50%
Lung Cancer
33%
Hip Fracture
33%
Ischemic Heart Disease
33%
Pulmonary Embolism
33%
Heart Failure
33%
Systemic Inflammation
16%
Diabetes
16%
Risk-adjusted
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Population-based Study
16%
Pneumonia
16%
Infarction
16%
Failure Type
16%
Hazard Ratio
16%
Confidence Interval
16%
Myocardial Infarction
16%
Hospital Admission
16%
Danish Population
16%
Medicine and Dentistry
Biological Marker
100%
Chronic Obstructive Pulmonary Disease
100%
Comorbidity
100%
C Reactive Protein
50%
Fibrinogen
50%
Leukocyte
50%
Congestive Heart Failure
33%
Ischemic Heart Disease
33%
Hip Fracture
33%
Lung Cancer
33%
Pulmonary Embolism
33%
Population Research
16%
Clinician
16%
Maturity Onset Diabetes of the Young
16%
Myocardial Infarction
16%
Hazard Ratio
16%
Diabetes
16%
Infarction
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Comorbidity
100%
Biological Marker
100%
C Reactive Protein
50%
Fibrinogen
50%
Hip Fracture
33%
Ischemic Heart Disease
33%
Lung Cancer
33%
Lung Embolism
33%
Congestive Heart Failure
33%
Heart Infarction
16%
Inflammation
16%
Infarction
16%
Non Insulin Dependent Diabetes Mellitus
16%
Population Study
16%
Immunology and Microbiology
Comorbidity
100%
C-Reactive Protein
50%
Leukocyte Count
50%
Fibrinogen
50%
Hip
33%
Systemic Inflammation
16%
Population Research
16%